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PREDICTION OF SEVERITY IN ACUTE
PANCREATITIS
ABSTRACT
Fan, ST, Choi, TK, Lai, ECS and Wong, J. (1989) Prediction of severity of acute
pancreatitis: an alternative approach. Gut; 30, 1591-1595
Admission laboratory data of 203 patients suffering from acute pancreatitis were
analysed to search for a simpler method of prediction of severity than the traditional
multifactor prognostic scoring system. By discriminant analysis, admission serum
urea and plasma glucose were identified to be factors with independent significance
in predicting severity. If the presence of either factor higher than the cutoff point
(urea > 7.4 mmoi/l, glucose > 11.0 mmol/l) was considered as an indication of severe
disease, then the sensitivity of this method was 75.0%, specificity 80.3% and the
accuracy 79.3%. The predictive ability of this method was comparable with the
Glasgow multifactor scoring system when the latter was also used to grade severity of
our patients. It has the advantage, however, of simplicity and the ability of
predicting severity at the time of admission.
PAPER DISCUSSION
KEY WORDS" Pancreatitis, acute
According to clinical and morphological criteria acute pancreatitis can be divided
into two subgroups. On the one hand, it is a self-limiting disease, morphologically
characterized by an interstitial edema within and outside the pancreatic gland,
sometimes with additional peripancreatic fatty tissue necrosis and linked to a
mortality rate of below 1%. On the other hand, there is the morphologically
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characterized hemorrhagic necrotizing form of acute pancreatitis with high morbi-
dity and mortality rates, despite new therapeutic procedures introduced recently.
In the literature a mortality rate of 10 to 15% for the clinically severe form of acute
pancreatitis is given, mainly caused by the bacterial contamination of the necroses,
followed by septic complications and multiple organ failure in the late phase of the
disease 1,2,3.
A precise and early discrimination between these two courses of acute pancreati-
tis has been the aim of many clinical studies in the past4’5. Among the clinical/
laboratory staging systems the Ranson score, comprising 11 different factors, is
most frequently used worldwide6. The study by Fan et al. also deals with the early
prediction of the degree of severity of acute pancreatitis. The laboratory analysis of
17 parameters revealed serum urea and plasma glucose as best suitable for the
prediction of the clinical severity of acute pancreatitis, with an accuracy rate of
about 80%. Unfortunately the authors do not supply any morphological data,
comparable to those of other studies today. In this respect contrast-enhanced
computed tomography must be mentioned particularly, as this method has estab-
lished itself worldwide as the "gold standard" in the staging of acute pancreatitis,
with a high degree (85-90%) of sensitivity and specificity in the detection of
necrotizing pancreatitis7’8. In the present paper an acute pancreatitis was grouped
as "severe" if the outcome was lethal, if more than one local or systemic
complication occurred, or if an emergency operation was necessary, due to "biliary
infection" or a complication of acute pancreatitis. According to this definition the
203 included patients were subdivided into a group of 163 with a mild, and another
group of 40 with a severe form of the disease. However, it is at least doubtful
whether patients with an emergency operation or with cholangitis, an exploration
of the biliary duct system or a perforated duodenal ulcer can be rightly included in
the "severe" group. Per se these diseases have nothing to do with an acute
pancreatitis or with a complication directly linked to it.
As early as 1974 Ranson and his co-workers
6 inaugurated a staging system for
acute pancreatitis on the basis of objective biochemical parameters and the
patients’ age. From a computerized analysis, consisting of 43 parameters, they
singled out 11, the amount of prognostic indices correlating directly with morbidity
and mortality. Unfortunately the authors do not give the so-called Ranson-points
for the two groups of acute pancreatitis they deal with, inspite of the fact that this
scoring system has gained general acceptance in the literature with regard to
stratification and comparability. They must be reproached with imitating Ranson’s
work, on the basis of 17 parameters only. As a reason for their prospective analysis
the authors cite three disadvantages of Ranson’s system: firstly, it comprises too
many factors; secondly, it necessitates an observation period of 48 hours for an
assessment; and thirdly, some parameters are considerably influenced by the
applied therapy. However, this last argument is particularly true for the serum
plasma glucose and serum urea levels. The authors examined the same 17
parameters 48 hours later, but do not give the results; it must be supposed
therefore, that still more laboratory parameters play a role in the discrimination
between mild and severe acute pancreatitis.
Apart from the development of new scoring systems, as for example the Glasgow
system1, several single biochemical parameters have been examined recently
5’ -7,
in order to achieve an early prognosis of acute pancreatitis. In prospective clinical
trials in which patients with acute pancreatitis were strictly subdivided according toHPB INTERNATIONAL 63
morphological criteria, high accuracy rates in the detection of pancreatic necroses
were achieved by an evaluation of C-reactive protein, PMN-elastase, lactate
dehydrogenase (LDH), catalytic phospholipase A2-activity (PLA2) and a
2-macroglobulin5,12,15,17.
In an analysis of the Department of General Surgery in Ulm, the calculated
accuracy rates for the correct prognosis of the degree of severity (morphology) of
acute pancreatitis within the first 5 pre-operative days after onset of the disease
were 86% for CRP (cut-off-level > 120 mg/l), 84% for PMN-elastase (> 120/g/1),
82% for LDH (> 270 U/l), 77% for the phospholipase A2-activity (> 3.5U/1) and
72% for a2-macroglobulin (< 1.5 g/l; 12, 15, 17). Thus, the first three parameters
exceed by far the accuracy rate of the combined serum urea and plasma glucose
levels, given by the authors, for the discrimination between mild and severe acute
pancreatitis.
In summary it must be admitted, that the present paper, based on a Chinese
patient collective and worked out according to clinical criteria, is an interesting
prospective analysis concerning the discrimination between mild and severe forms
of acute pancreatitis. However, it does not supply new insights to the clinically
active colleagues.
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PANCREATIC DRAINAGE INTO THE STOMACH
AFTER PANCREATIC RESECTION
ABSTRACT
Delcore, R., Thomas, J.H., Pierce, G.E. and Hermreck, A.S. (1990)
Pancreatogastrostomy: A safe drainage procedure after pancreatoduodenectomy.
Surgery; 108:641-647
The purpose of this study was to evaluate the role of pancreaticogastrostomy as an
alternative method of restoring pancreaticointestinal continuity after pancreatico-
duodenectomy. Since 1975, 45 patients have undergone pancreaticogastrostomy
after pancreaticoduodenectomy at our institution. Pancreaticoduodenectomy was
performed for pancreatic carcinoma (24 patients), ampullary carcinoma (8
patients), duodenal carcinoma (4 patients), common bile duct carcinoma (4
patients), pancreatic islet cell carcinoma (1 patient), trauma (1 patient), extensive
colon carcinoma (1 patient), chronic pancreatitis (1 patient), and gastroduodenal
artery aneurysm (1 patient). There was one operative death, for an overall operative
mortality rate of2%, and seven patients had major postoperative complications, for
an overall morbidity rate of 15%. No pancreatic anastomotic leaks or other
complications related to the pancreaticogastrostomy occurred. Twenty-four patients
have died of recurrent carcinoma, with a mean survival of 25 months (range, 5 to 66
months), and 20 patients are alive and well, with a mean follow-up of 27 months
(range, 2 to 106 months). Eight of these patients are alive 2 or more years after
operation and four do not have exocrine pancreatic insufficiency. This experience
confirms that pancreaticogastrostomy is a safe method of pancreatic drainage after
pancreaticoduodenectomy and suggests that it may have technical advantages and
therefore merits more widespread application. (Surgery 1990; 108:641-7.)